24H | Celestica Soars 10%; Confluent Climbs 9%; NXP Semiconductors Gains 2.5%; Galaxy Digital Sinks 8%

Tiger Newspress
Oct 28, 2025

Celestica shares rose 10% in overnight trading. Celestica reported Q3 adjusted earnings late Monday of $1.58 per diluted share, up from $1.04 a year earlier. Revenue for the three months ended Sept. 30 was $3.19 billion, up from $2.50 billion a year earlier.

Confluent shares rose nearly 9% after reporting third quarter 2025 financial results, with total revenue of $298.5 million, up 19% from $250.2 million in the third quarter of 2024.

Subscription revenue reached $286.3 million, increasing 19% from $239.9 million in the same period last year.

NXP reported third-quarter revenue of $3.02 billion, missing analyst estimates of $3.16 billion. The chipmaker reported adjusted earnings of $3.11 per share for the third quarter, in line with analyst estimates. Shares of NXP Semiconductors jumped 2.55% after earnings report.

Universal Health Services beat Wall Street estimates for third-quarter profit on Monday, driven by steady demand for medical care services at its hospitals, sending its shares surging 6% in overnight trading.

NXP expects fourth-quarter revenue of $3.2 billion to $3.4 billion versus estimates of $3.24 billion. The company sees fourth-quarter adjusted earnings in the range of $3.07 to $3.49 per share, versus estimates of $3.29 per share.

Galaxy Digital stock sank 7.7% in overnight trading. Galaxy Digital Inc. has announced a private offering of $1.0 billion aggregate principal amount of exchangeable senior notes due 2031.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10